Literature DB >> 15315646

The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine.

V Binnie1, S McHugh, L Macpherson, B Borland, K Moir, K Malik.   

Abstract

OBJECTIVES: Cotinine, a nicotine metabolite, can be used to measure exposure to tobacco smoke. The aim of this study was to compare cotinine levels in different biological fluids collected from both smokers and non-smokers and to relate the findings to self-reported smoking status. Data were also collected concerning the acceptability of the differing methods of sample collection. MATERIAL AND
METHOD: Patients recruited to the study were asked to provide samples of urine, blood and saliva (both stimulated and unstimulated). Data collected from patients by questionnaire included information on smoking behaviour such as daily number of cigarettes and environmental exposure to smoke. After the sample collection, patients were asked to rate the acceptability of each sampling method. Samples were analysed using enzyme immunoassay (EIA) kits.
RESULTS: In total, 80 patients participated, with 49 being smokers and 31 being non-smokers. There was clear differentiation between smokers and non-smokers (P < 0.001) for all the different samples in terms of cotinine. A significant relationship was seen between cotinine and daily number of cigarettes for both salivas and urine (all P < 0.001) but not for serum. Participants found serum and urine collection methodologies 'very acceptable' (67 and 66%, respectively) whereas 9% found collection of stimulated saliva 'not at all acceptable'.
CONCLUSION: Cotinine, whatever the collection method and analysed by EIA kits, shows good differentiation between smokers and non-smokers. Salivary samples have the advantage of being non-invasive, although collection methodology is important, as cotinine levels may vary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315646     DOI: 10.1111/j.1601-0825.2004.01018.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  35 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

2.  Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.

Authors:  Melania Dovizio; Stefania Tacconelli; Emanuela Ricciotti; Annalisa Bruno; Thorsten Jürgen Maier; Paola Anzellotti; Luigia Di Francesco; Paola Sala; Stefano Signoroni; Lucio Bertario; Dan A Dixon; John A Lawson; Dieter Steinhilber; Garret A FitzGerald; Paola Patrignani
Journal:  J Pharmacol Exp Ther       Date:  2012-01-19       Impact factor: 4.030

3.  Variations in Cigarette Smoking and Quit Attempts by Health Insurance Among US Adults in 41 States and 2 Jurisdictions, 2014.

Authors:  Shillpa Naavaal; Ann Malarcher; Xin Xu; Lei Zhang; Stephen Babb
Journal:  Public Health Rep       Date:  2018-02-23       Impact factor: 2.792

4.  Oral fluid nicotine markers to assess smoking status and recency of use.

Authors:  Karl B Scheidweiler; Gina F Marrone; Diaa M Shakleya; Edward G Singleton; Stephen J Heishman; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

5.  Effect of incorporating a 10 minute point of care test for salivary nicotine metabolites into a general practice based smoking cessation programme: randomised controlled trial.

Authors:  Kristian D Barnfather; Graham F Cope; Iain L Chapple
Journal:  BMJ       Date:  2005-10-06

6.  Natural Course of Nicotine Dependence Among Adolescent Waterpipe and Cigarette Smokers.

Authors:  Mohammad Ebrahimi Kalan; Raed Behaleh; Joseph R DiFranza; Zoran Bursac; Ziyad Ben Taleb; Malak Tleis; Taghrid Asfar; Rima Nakkash; Kenneth D Ward; Thomas Eissenberg; Wasim Maziak
Journal:  J Adolesc Health       Date:  2020-07-02       Impact factor: 5.012

7.  Carboxyhaemoglobin concentration, smoking habit, and mortality in 25 years in the Renfrew/Paisley prospective cohort study.

Authors:  C L Hart; G Davey Smith; D J Hole; V M Hawthorne
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

8.  Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes.

Authors:  Yu Ohmura; Taiki Takahashi; Nozomi Kitamura
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

9.  Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluid.

Authors:  Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-10-18       Impact factor: 4.142

10.  Assessment of smoking behaviors and alcohol use in the national social life, health, and aging project.

Authors:  Melinda L Drum; Sharon Shiovitz-Ezra; Elyzabeth Gaumer; Stacy T Lindau
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-01-30       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.